Immediate post-procedural QRS duration as a trigger for prompt discharge after transcatheter and surgical aortic valve replacement
Background Conduction disturbances requiring permanent pacemaker implantation (PPI) after transcatheter (TAVR) or surgical aortic valve replacement (SAVR) increase length of stay. This study aimed to assess the predictive value of immediate post-procedural electrocardiographic (ECG) features for PPI within 30 days to identify candidates for early discharge. Methods A single-center study was conducted among patients aged ≥75 years who underwent TAVR or SAVR between 2014 and 2020. 12‑lead ECGs were analyzed before the procedure, immediately after (Day 0), at discharge and 30 days. Results In total, 365 patients were included in the study (221 TAVR and 144 SAVR; mean age 83 ± 5 years; Society of Thoracic Surgeons score 4.5 (2.2–5.5)), achieving similar 30-day survival rates (99 vs. 97%; p = NS). Both TAVR and SAVR induced QRS widening, peaking at Day 0 (122 ± 29 vs. 109 ± 29 ms, respectively; p < 0.05). QRS duration at Day 0 (QRS 0 ) was an independent predictor of PPI in both groups (hazard ratio [HR] 1.38 [1.22–1.56] and 1.28 [1.14–1.45], respectively; p < 0.001). A QRS 0 cut-off value was identified at 150 ms after TAVR and 148 ms after SAVR. Patients with a QRS 0 < 150 ms and a PR interval < 200 ms were categorized as low risk, with only 3% requiring PPI at 30 days. Conclusions QRS 0 was an independent predictor of PPI, with a similar cut-off after TAVR and SAVR. Patients in sinus rhythm with a QRS 0 < 150 ms and a PR interval < 200 ms were categorized as low risk, that may help identify candidates for early discharge after TAVR and SAVR.
Authors
- Joëlle Kefer (ORCID: https://orcid.org/0000-0001-8338-908X)
- Gaby Aphram
- Christophe Scavée (ORCID: https://orcid.org/0000-0002-6047-8757)
- Shakeel Kautbally (ORCID: https://orcid.org/0000-0003-2026-951X)
- Marine Delacour
- Laurent de Kerchove (ORCID: https://orcid.org/0000-0002-2967-8099)
- Frédéric Maes (ORCID: https://orcid.org/0000-0002-2384-6493)
- Varnavas Varnavas (ORCID: https://orcid.org/0000-0001-9715-1611)
- Sébastien Marchandise (ORCID: https://orcid.org/0000-0002-5165-056X)
- Marin Boute (ORCID: https://orcid.org/0009-0005-5046-6639)
- Camille Laivier
Institutions
- Cliniques Universitaires Saint-Luc (BE)
- UCLouvain (BE)
Publication Details
- Journal
- IJC Heart & Vasculature
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1016/j.ijcha.2026.102044
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00